Provided by Tiger Fintech (Singapore) Pte. Ltd.

Petros Pharmaceuticals Inc

0.0302
+0.00279.78%
Volume:862.82K
Turnover:25.42K
Market Cap:940.72K
PE:0.00
High:0.0325
Open:0.0283
Low:0.0267
Close:0.0275
Loading ...
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 26, 2022

Major Issues Report

8-K - Current report
Apr 04, 2022

Major Issues Report

8-K - Current report
Apr 01, 2022

Major Issues Report

8-K/A [Amend] - Current report
Mar 31, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 23, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 24, 2022

Major Issues Report

8-K - Current report
Jan 21, 2022

Major Issues Report

8-K - Current report
Jan 12, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jan 12, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jan 06, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 27, 2021

Major Issues Report

8-K - Current report
Dec 23, 2021

Major Issues Report

8-K - Current report
Dec 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 13, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 01, 2021

Major Issues Report

8-K - Current report